Deucravacitinib in the Treatment of Cicatricial Alopecias

NCT07508488 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Central Centrifugal Cicatricial Alopecia
Frontal Fibrosing Alopecia

Interventions

DRUG: Deucravacitinib

Sponsor

Icahn School of Medicine at Mount Sinai

Collaborators

[object Object]